These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 11276966)

  • 1. Analysis of drugs of abuse in urine by gas chromatography/mass spectrometry: experience and application.
    Karacić V; Skender L
    Arh Hig Rada Toksikol; 2000 Dec; 51(4):389-400. PubMed ID: 11276966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of 19 drugs of abuse and metabolites in whole blood by high-performance liquid chromatography-tandem mass spectrometry.
    Bjørk MK; Nielsen MK; Markussen LØ; Klinke HB; Linnet K
    Anal Bioanal Chem; 2010 Apr; 396(7):2393-401. PubMed ID: 19921510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sweat testing in opioid users with a sweat patch.
    Kintz P; Tracqui A; Mangin P; Edel Y
    J Anal Toxicol; 1996 Oct; 20(6):393-7. PubMed ID: 8889674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hair analysis for illicit drugs by using capillary zone electrophoresis-electrospray ionization-ion trap mass spectrometry.
    Gottardo R; Bortolotti F; De Paoli G; Pascali JP; Miksík I; Tagliaro F
    J Chromatogr A; 2007 Aug; 1159(1-2):185-9. PubMed ID: 17240388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of drugs of abuse in blood.
    Moeller MR; Steinmeyer S; Kraemer T
    J Chromatogr B Biomed Sci Appl; 1998 Aug; 713(1):91-109. PubMed ID: 9700554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validated toxicological determination of 30 drugs of abuse as optimized derivatives in oral fluid by long column fast gas chromatography/electron impact mass spectrometry.
    Gunnar T; Ariniemi K; Lillsunde P
    J Mass Spectrom; 2005 Jun; 40(6):739-53. PubMed ID: 15806585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the validity of gas chromatography-mass spectrometry and liquid chromatography-tandem mass spectrometry analysis of urine samples II: amphetamine, methamphetamine, (±)-3,4-methylenedioxyamphetamine, (±)-3,4-methylenedioxymethamphetamine, (±)-3,4-methylenedioxyethylamphetamine, phencyclidine, and (±)-11-nor-9-carboxy-Δ⁹-tetrahydrocannabinol.
    Stout PR; Bynum ND; Lewallen CM; Mitchell JM; Baylor MR; Ropero-Miller JD
    J Anal Toxicol; 2010 Oct; 34(8):430-43. PubMed ID: 21819787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid screening of drugs of abuse and their metabolites by gas chromatography/mass spectrometry: application to urinalysis.
    Strano-Rossi S; Molaioni F; Rossi F; Botrè F
    Rapid Commun Mass Spectrom; 2005; 19(11):1529-35. PubMed ID: 15880665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Confirmatory tests for drugs in the workplace by gas chromatography-mass spectrometry.
    Goldberger BA; Cone EJ
    J Chromatogr A; 1994 Jul; 674(1-2):73-86. PubMed ID: 8075776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A GC-MS method for the detection and quantitation of ten major drugs of abuse in human hair samples.
    Orfanidis A; Mastrogianni O; Koukou A; Psarros G; Gika H; Theodoridis G; Raikos N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar; 1047():141-150. PubMed ID: 27884570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of illicit drugs and their metabolites in human urine by liquid chromatography tandem mass spectrometry including relative ion intensity criterion.
    Concheiro M; De Castro A; Quintela O; Cruz A; López-Rivadulla M
    J Anal Toxicol; 2007; 31(9):573-80. PubMed ID: 18093416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the ion-trap mass spectrometer for routine qualitative and quantitative analysis of drugs of abuse extracted from urine.
    Vorce SP; Sklerov JH; Kalasinsky KS
    J Anal Toxicol; 2000 Oct; 24(7):595-601. PubMed ID: 11043665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a gas chromatography-mass spectrometry method for opiates and cocaine in human bone.
    Fernandez-Lopez L; Luna-Maldonado A; Falcon M; Mastrobattista L; Navarro-Zaragoza J; Mancini R
    J Pharm Biomed Anal; 2019 Feb; 164():636-641. PubMed ID: 30471636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid analysis of metabolites and drugs of abuse from urine samples by desorption electrospray ionization-mass spectrometry.
    Kauppila TJ; Talaty N; Kuuranne T; Kotiaho T; Kostiainen R; Cooks RG
    Analyst; 2007 Sep; 132(9):868-75. PubMed ID: 17710261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two new standard reference materials for the determination of drugs of abuse in human hair.
    Welch MJ; Sniegoski LT; Tai S
    Anal Bioanal Chem; 2003 Aug; 376(8):1205-11. PubMed ID: 12879199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioanalytical procedures for determination of drugs of abuse in blood.
    Kraemer T; Paul LD
    Anal Bioanal Chem; 2007 Aug; 388(7):1415-35. PubMed ID: 17468860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous determination in hair of multiclass drugs of abuse (including THC) by ultra-high performance liquid chromatography-tandem mass spectrometry.
    Di Corcia D; D'Urso F; Gerace E; Salomone A; Vincenti M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jun; 899():154-9. PubMed ID: 22626893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a direct high-capacity target screening approach for urine drug testing using liquid chromatography-time-of-flight mass spectrometry.
    Saleh A; Stephanson NN; Granelli I; Villén T; Beck O
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Nov; 909():6-13. PubMed ID: 23153637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drugs of abuse monitoring in blood for control of driving under the influence of drugs.
    Moeller MR; Kraemer T
    Ther Drug Monit; 2002 Apr; 24(2):210-21. PubMed ID: 11897967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new mixed mode solid phase extraction strategy for opioids, cocaines, amphetamines and adulterants in human blood with hybrid liquid chromatography tandem mass spectrometry detection.
    Dowling G; Regan L
    J Pharm Biomed Anal; 2011 Apr; 54(5):1136-45. PubMed ID: 21194869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.